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Research article 
Diagnostic errors in clinical FDG-PET/CT 
Norah A. Alotaibi , Derya Yakar , Andor W.J.M. Glaudemans , Thomas C. Kwee * 
Medical Imaging Center, Department of Radiology, Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Center Groningen, the 
Netherlands   






A B S T R A C T   
Purpose: To determine the frequency, types, and determinants of diagnostic errors in clinical FDG-PET/CT, based 
on addenda to the original report. 
Materials and Methods: This retrospective study included 4,099 consecutive clinical FDG-PET/CT scans with 
corresponding reports that were made at a tertiary care center in an 18-month period. FDG-PET/CT reports were 
scrutinized for the presence of an addendum enclosing a diagnostic error. 
Results: 90 of 4,099 FDG-PET/CT reports (2.2%) contained an addendum enclosing a diagnostic error. The 
distribution of perceptual and cognitive errors among these 90 diagnostic errors was 54 (60.0%)/36 (40.0%). On 
multivariate logistic regression analysis, only low-dose FDG-PET/CT combined with concomitantly acquired and 
interpreted full-dose contrast-enhanced CT remained as significantly and independently associated with the 
presence of a diagnostic error, relative to low-dose FDG-PET/CT without concomitantly acquired and interpreted 
full-dose contrast-enhanced CT (odds ratio: 2.79 [95% confidence interval: 1.61-4.85], P < 0.001). Patient age, 
gender, hospital status, indication for FDG-PET/CT scanning, single vs. double reading (i.e. two medical imaging 
specialists), reader experience, and reading by a nuclear medicine physician only vs. reading by both a nuclear 
medicine physician and a radiologist, were not significantly and independently associated with the presence of a 
diagnostic error. 
Conclusion: Diagnostic errors in clinical FDG-PET/CT based on addenda to the original report are relatively 
infrequent, though certainly non-negligible. Perceptual errors are slightly more frequent than cognitive errors. 
The availability of a concomitantly acquired and interpreted full-dose contrast-enhanced CT seems to increase 
diagnostic error rate. These data can be used for quality improvement and benchmarking purposes.   
1. Introduction 
Integrated positron emission tomography (PET)/computed tomog-
raphy (CT) with the radiotracer 18F-fluoro-2-deoxy-D-glucose (FDG) is 
an established imaging modality for the evaluation of a wide range of 
human diseases [1]. Accurate interpretation of FDG-PET/CT scans is 
crucial for correct patient management in terms of further diagnostic 
testing, treatment planning, and prognostic purposes. However, inter-
pretation of medical imaging examinations is a complex process that is 
error prone [2]. 
Diagnostic errors can be broadly divided into perceptual errors (i.e. 
detection errors) and cognitive (interpretive) errors (i.e. decision errors 
in the perception of an abnormality) [2]. It has been reported that, with 
estimates of average diagnostic error rates ranging from 3% to 5%, there 
are approximately 40 million diagnostic errors involving imaging 
annually worldwide [3]. These diagnostic errors may not only harm the 
patient, but are also responsible for a considerable amount of unnec-
essary healthcare costs due to wasteful medical spending, and are a 
major cause of malpractice lawsuits against medical professionals [3]. If 
a diagnostic error is made, it is common practice to create an addendum 
to correct or expand on the original radiology report [4]. As such, 
addenda provide a valuable source to investigate errors in the inter-
pretation of imaging studies [5]. 
Currently, there is a lack of literature on diagnostic errors in clinical 
FDG-PET/CT. Analysis of diagnostic errors in FDG-PET/CT and the 
circumstances under which they occur, may provide strategies for error 
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mography; SPSS, statistical package for the social sciences. 
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reduction, and thereby improve patient care [2,3]. It can be hypothe-
sized that certain patient variables (age, gender, in- or outpatient status, 
indication for FDG-PET/CT scanning), FDG-PET/CT scan acquisition 
method (low-dose FDG-PET/CT with or without concomitant full-dose 
contrast-enhanced CT), and FDG-PET/CT interpretation circumstances 
(single vs. double reading, reader experience, and reading by a nuclear 
medicine physician only vs. reading by both a nuclear medicine physi-
cian and a radiologist) may have an effect on diagnostic error rate. 
The purpose of this study was to determine the frequency, types, and 
determinants of diagnostic errors in clinical FDG-PET/CT, based on 
addenda to the original reports. 
2. Materials and Methods 
2.1. Study design 
This study was performed at the University Medical Center Gronin-
gen, which is a tertiary care center that provides healthcare services to 
over 2 million inhabitants in the north-east of the Netherlands. The local 
institutional review board approved this retrospective study, and the 
requirement for informed consent was waived. All consecutive FDG- 
PET/CT scans that were performed between April 2016 and November 
2017, were potentially eligible for inclusion. FDG-PET/CT scans were 
included if they involved mid-thigh to cranial vertex or feet to cranial 
vertex acquisitions, and if they were interpreted and reported by nuclear 
medicine physicians and/or radiologists as part of standard clinical care. 
FDG-PET/CT scans were excluded if they only involved specific body 
regions (e.g. brain, heart, or extremities), or if a clinical FDG-PET report 
was lacking (this may have been the case if the FDG-PET/CT scan was 
acquired at the request of another institution, or if the FDG-PET/CT scan 
was performed for research purposes). 
2.2. FDG-PET/CT acquisition 
FDG-PET/CT scans were acquired according to the European Asso-
ciation of Nuclear Medicine (EANM) procedure guidelines for tumor 
imaging [6], using integrated PET/CT systems (Biograph 40 or 64 mCT 
PET/CT, Siemens Healthineers, Erlangen, Germany). All patients fasted 
for at least 6 hours before 3 MBq/kg FDG was administered intrave-
nously. Sixty minutes later, PET scanning was performed from either 
mid-thigh to cranial vertex or feet to cranial vertex, depending on the 
clinical indication of the scan. Low-dose (100 kV and 30 mAs) unen-
hanced CT scanning was performed for attenuation correction and 
anatomic mapping. Concomitant full-dose (constant tube potential of 
100-120 kV with automatic tube current modulation in the z-direction) 
contrast-enhanced CT was performed in a subset of patients, depending 
on the clinical indication, directly after low-dose FDG-PET/CT using the 
same PET/CT system. 
Table 1 
Patient, FDG-PET/CT acquisition, and FDG-PET/CT interpretation characteris-
tics belonging to the 4,099 FDG-PET/CT scans that were included in this study.  
Variable No.a 
Patient age (years) 57.9 ± 17.0 






Inpatient 564 (13.8%) 
Outpatient 3,535 
(86.2%) 
Clinical indication for FDG-PET/CT 
Oncological 3,401 
(83.0%) 
Infection 291 (7.1%) 
Inflammation 216 (5.3%) 
Other 191 (4.7%) 
FDG-PET/CT scan range 
Mid-thigh to cranial vertex 3,588 
(87.5%) 
Feet to cranial vertex 511 (12.5%) 
Concomitant full-dose contrast-enhanced CT 
Yesb 2,133 (52.%) 
No 1,966 
(48.0%) 





Experience of first reader (years)c,d 8.13 ± 6.8 
Experience of second reader (years)c,d 7.4 ± 5.9 
Reader of FDG-PET/CT scan 
Nuclear medicine physician only 2,006 
(60.4%) 
Nuclear medicine physician and radiologist 1,313 
(39.6%) 
Presence of an addendum 
Yes 123 (3%) 
No 3,976 (97%) 
Time between the authorization of the original report and the 
addendum (days) 
6 (2-14) 
Presence of an addendum enclosing a diagnostic error 
Yes 90 (73.2%) 
No 33 (26.8%) 
Person who made the addendum  
Person who made the addendum was the same as the one who made 
the original report 
61 (67.8%) 
Person who made the addendum was not the same as the one who 
made the original report 
29 (32.3%) 
Time between the authorization of the original report and the 
addendum enclosing a diagnostic error (days) 
6.5 (2-13) 
Notes: 
a Data are presented as No. (%), median (interquartile range), or mean ± SD. 
b Full-dose contrast-enhanced CT was made of the following body regions: 
chest (n = 674), chest-abdomen (n = 589), neck-chest-abdomen (n = 517), neck- 
chest (n = 118), abdomen (n = 91), neck (n = 75), heart (n = 59), abdomen-legs 
(n = 7), neck-abdomen (n = 2), neck-chest-abdomen-legs (n = 1). 
c Only medical imaging specialists (radiologists or nuclear medicine physi-
cians) were counted. 
d Readers’ experience after completion of residency. 
Table 2 
Anatomic locations of all perceptual and cognitive errors.  
Perceptual errors (n = 54) Cognitive errors (n = 36) 
Lymph nodes (n = 12) Bowel (n = 3) 
Vascular (n = 6) Lung (n = 3) 
Bone (n = 5) Lymph nodes (n = 3) 
Bowel (n = 3) Subcutaneous tissue (n = 3) 
Brain (n = 3) Thyroid (n = 3) 
Liver (n = 3) Lung and lymph nodes (n = 2) 
Spine (n = 3) Oropharynx (n = 2) 
Kidney (n = 2) Stomach (n = 2) 
Lung (n = 2) Bone (n = 1) 
Thyroid (n = 2) Brain (n = 1) 
Uterus (n = 2) Breast (n = 1) 
Anatomic location not specifiable 
(n = 2) 
Esophagus (n = 1) 
Abdominal wall (n = 1) Heart (n = 1) 
Bone and bowel (n = 1) Liver (n = 1) 
Bone and lymph nodes (n = 1) Lung and lymph nodes (n = 1) 
Brain and kidney (n = 1) Mediastinum (n = 1) 
Breast (n = 1) Muscle and skin (n = 1) 
Heart (n = 1) Pancreas (n = 1) 
Skin (n = 1) Skin (n = 1) 
Spleen (n = 1) Spleen and lymph nodes (n = 1) 
Urinary bladder (n = 1) Subcutaneous tissue, lymph nodes and bone 
(n = 1)  
Uterus (n = 1)  
Anatomic location not specifiable (n = 1)  
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2.3. FDG-PET/CT interpretation 
All low-dose FDG-PET/CT scans were interpreted by nuclear medi-
cine physicians. All full-dose contrast-enhanced CT scans were inter-
preted by either radiologists or nuclear medicine physicians with 
national board certification in diagnostic CT interpretation (the latter 
group also interpreted the low-dose FDG-PET/CT scans by themselves). 
Low-dose FDG-PET/CT and full-dose contrast-enhanced CT were first 
reviewed separately, potential discrepancies were then discussed to 
reach consensus, and the findings of both modalities were finally inte-
grated into one single report, in case two readers were involved. Low- 
dose FDG-PET/CT was always interpreted before full-dose contrast- 
enhanced CT, and the low-dose FDG-PET/CT scan and the correspond-
ing preliminary report were available for review to the full-dose 
contrast-enhanced CT reader. Dedicated software (Syngo.via, Siemens 
Healthineers, Erlangen, Germany) was used for FDG-PET/CT interpre-
tation, which allowed for side-by-side display of (low-dose and full-dose 
contrast-enhanced) CT, FDG-PET, and fused FDG-PET and (low-dose and 
full-dose contrast-enhanced) CT datasets. Addenda, if present, could 
have been made by either the same nuclear medicine physician or 
radiologist who created the original report, or a different one who was 
not involved in the original reading of the FDG-PET/CT scan. 
Fig. 1. A 55-year-old man with a history of coronary artery bypass surgery and recent endoscopic mucosal resection of an esophageal cancer. Low-dose FDG-PET/CT 
and concomitant full-dose contrast-enhanced CT were performed for staging purposes. Coronal maximum intensity projection FDG-PET (A), axial FDG-PET (B), axial 
low-dose CT (C), axial fused FDG-PET/CT (D), and axial full-dose contrast-enhanced CT (E) are demonstrated. Low-dose PET/CT showed physiologically increased 
FDG uptake at the sternotomy site (A-D, arrowheads), but otherwise no signs of metastatic disease. Contrast-enhanced CT showed emboli in both lower lobes (E, 
arrows), which were not visible on low-dose FDG-PET/CT. These pulmonary emboli were not described in the original report. This perceptual error was corrected 
with an addendum five days after authorization of the original report. 
Fig. 2. A 59-year-old woman with fever of unknown origin. Low-dose FDG-PET/CT was performed to search for an infectious focus. Coronal low-dose CT (A, C) with 
corresponding coronal fused FDG-PET/CT (B, D) slices at two different levels are demonstrated. No infectious focus was found at FDG-PET/CT. Although both 
kidneys contained masses with low FDG avidity (A-D, arrows), they were not described in the original report. These masses proved to be clear cell renal cell car-
cinomas on follow-up. This perceptual error was corrected with an addendum 14 days after authorization of the original report. 
N.A. Alotaibi et al.                                                                                                                                                                                                                             
European Journal of Radiology 132 (2020) 109296
4
2.4. Data extraction 
A research fellow (N.A.A.) manually scrutinized all FDG-PET reports 
performed between April 2016 and November 2017, and applied the 
previously mentioned in- and exclusion criteria. For all FDG-PET/CT 
reports that were included, the following variables were extracted: pa-
tient age and gender, hospital status (in- or outpatient), indication for 
FDG-PET/CT scanning (oncology, infection, inflammation, or other), 
Fig. 3. A 69-year-old man with a history of chronic lym-
phocytic leukemia and palpable lymphomas in the right 
axilla. Low-dose FDG-PET/CT and concomitant full-dose 
contrast-enhanced CT were performed for staging pur-
poses. Coronal maximum intensity projection FDG-PET (A), 
axial low-dose CT (B), axial fused FDG-PET/CT (C), and 
axial full-dose contrast-enhanced CT (E) are demonstrated. 
FDG-PET showed right axillary lymphomas with low FDG- 
avidity (A, arrow) and focal high FDG uptake in the distal 
esophagus (A, arrowhead), the latter suspicious for esoph-
ageal cancer. Although right para-iliac non-FDG-avid lym-
phomas were also visible (B-D, arrows), they were not 
described in the original report. This perceptual error was 
corrected with an addendum 22 days after authorization of 
the original report.   
Fig. 4. A 62-year-old woman who had undergone neo- 
adjuvant chemoradiation therapy for esophageal cancer. 
Low-dose FDG-PET/CT was performed for restaging pur-
poses. Coronal maximum intensity projection FDG-PET (A), 
axial FDG-PET (B), and axial low-dose CT (C) are demon-
strated. FDG-PET showed high FDG uptake at the location 
of the primary tumor (A, arrow) that had decreased 
compared to baseline FDG-PET (not shown). Although a 
mass with peripheral high FDG uptake was present in the 
right cerebellar hemisphere (B and C, arrowheads), this 
was not described in the original report. Follow-up 
confirmed metastatic disease. This perceptual error was 
corrected with an addendum 7 days after authorization of 
the original report.   
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FDG-PET/CT scan range (mid-thigh to cranial vertex or feet to cranial 
vertex), presence of absence of concomitantly acquired full-dose 
contrast-enhanced CT that was interpreted together with low-dose 
FDG-PET/CT, number and function (nuclear medicine physician or 
radiologist) of FDG-PET/CT readers, readers’ experience after comple-
tion of residency, presence or absence of an addendum, and time be-
tween authorization of the original report and the addendum. If an 
addendum was present, it was classified as either due to diagnostic error 
or not related to diagnostic error (e.g. addenda with a correction of 
typographic errors or addenda with purely research-related assess-
ments). Note that addenda with purely research-related assessments 
refer to addenda appended to clinical reports and that contain infor-
mation that is used for research purposes only. E.g. an oncological FDG- 
PET/CT scan with a clinical report and an addendum in which addi-
tional measurements are documented for a certain study. Diagnostic 
errors were subsequently classified as either perceptual or cognitive [2]. 
2.5. Statistical analysis 
The frequency of diagnostic errors enclosed in all addenda as a 
proportion of the total amount of FDG-PET/CT reports was calculated, 
along with 95% confidence intervals (CIs). Proportions of perceptual 
and cognitive errors were also calculated. Logistic regression analyses 
were performed to determine the association between the previously 
mentioned patient, FDG-PET/CT acquisition, and FDG-PET/CT inter-
pretation variables with the presence of a diagnostic error. Variables 
with a P-value <0.10 on univariate logistic regression analysis were 
selected for subsequent multivariate logistic regression analysis. Vari-
ables with a P-value <0.05 on multivariate logistic regression analysis 
were considered to be significantly and independently associated with 
the presence of a diagnostic error. Statistical analyses were executed 
using the IBM Statistical Package for the Social Sciences (SPSS), version 
25 (IBM SPSS, Armonk, NY, USA). 
3. Results 
3.1. FDG-PET/CT scans and reports 
Between April 2016 and November 2017, 6,500 FDG-PET/CT scans 
were acquired. Of these 6,500 FDG-PET/CT scans, 1,789 were excluded 
because they only involved specific body regions (brain [n = 1,763], 
heart [n = 12], extremities [n = 14]), and 612 were excluded because a 
corresponding report was lacking. Thus, a total of 4,099 FDG-PET/CT 
scans with corresponding reports were included. Patient, FDG-PET/CT 
acquisition, and FDG-PET/CT interpretation characteristics belonging 
to the 4,099 FDG-PET/CT scans that were included in this study are 
displayed in Table 1. 
3.2. Frequency and types of diagnostic errors 
123 of 4,099 FDG-PET/CT reports contained an addendum, of which 
90 enclosed a diagnostic error. Consequently, the diagnostic error fre-
quency was 2.2% (95% CI: 1.8-2.7%). The distribution of perceptual and 
cognitive errors among these 90 diagnostic errors was 54 (60.0%)/36 
Fig. 5. A 59-year-old man who had received chemo-
radiation therapy for right-sided tonsillar cancer. Low-dose 
FDG-PET/CT was performed for staging purposes. Coronal 
maximum intensity projection FDG-PET (A), axial FDG-PET 
(B), axial low-dose CT (C), and axial fused FDG-PET/CT (D) 
are demonstrated. FDG-PET showed physiological FDG- 
avid brown fat in the bilateral cervical and paravertebral 
regions (A, arrowheads). Furthermore, an FDG-avid focus 
in the right side of the neck (B and D, arrows) was 
described as a possible lymph node metastasis in the orig-
inal report. However, CT image at the same level (C) 
showed the FDG-avid focus in the right side of the neck to 
be localized in fatty tissue, and not in a lymph node. 
Therefore, it most likely also represented physiological 
FDG-avid brown fat. This cognitive error was corrected 
with an addendum two days after authorization of the 
original report.   
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(40.0%). The anatomic locations of all perceptual and cognitive errors 
are displayed in Table 2. Case examples of perceptual errors are shown 
in Figs. 1–4, and case examples of cognitive errors are shown in 
Figs. 5–8. 
3.3. Determinants of diagnostic errors 
On univariate logistic regression analysis, low-dose FDG-PET/CT 
scans with concomitantly acquired and interpreted full-dose contrast- 
enhanced CT, more frequently suffered from diagnostic errors than those 
without (P < 0.001). In addition, FDG-PET/CT scans read by a nuclear 
medicine physician only, more frequently suffered from diagnostic er-
rors than those read by both a nuclear medicine physician and a radi-
ologist (P = 0.06). All other variables (patient age, gender, and hospital 
status, indication for FDG-PET/CT scanning, single vs. double reading (i. 
e. two medical imaging specialists), and reader experience) did not 
reach P-values less than 0.10 on univariate logistic regression analysis 
(Table 2). On multivariate logistic regression analysis, only low-dose 
FDG-PET/CT combined with concomitantly acquired and interpreted 
full-dose contrast-enhanced CT remained as significantly and indepen-
dently associated with the presence of a diagnostic error, relative to low- 
dose FDG-PET/CT without concomitantly acquired and interpreted full- 
dose contrast-enhanced CT (odds ratio of 2.79 [95% confidence interval: 
1.61-4.85], P < 0.001) (Table 3). 
3.4. Post-hoc analysis 
From our preplanned analysis as executed in the previous section, it 
emerged that a higher error rate exists when a diagnostic-quality CT 
scan is available. We speculated that this is due to either the added 
structural information from the diagnostic-quality CT scan that is not 
visible on FDG-PET and/or satisfaction of search after the initial FDG- 
PET interpretation. To support this hypothesis, the proportion of 
perceptual errors was compared between low-dose FDG-PET/CT only 
and low-dose FDG-PET/CT combined with full-dose contrast-enhanced 
CT. In addition, the proportions of perceptual errors in the latter group 
(i.e. low-dose FDG-PET/CT combined with full-dose contrast-enhanced 
CT) that were due to findings that were visible on CT only, on FDG-PET 
only, and on both FDG-PET and CT, were calculated. 
The post-hoc analysis of all 90 diagnostic errors revealed that, 
proportion-wise, perceptual errors were more common when low-dose 
FDG-PET/CT was combined with full-dose contrast-enhanced CT (39/ 
60, 65.0%) than when it was not (15/30, 50.0%). In addition, the ma-
jority of perceptual errors in the 39 low-dose FDG-PET/CT scans that 
were combined with full-dose contrast-enhanced CT, were due to find-
ings that were visible on CT only (22/39, 56.4%), while the remainder 
was due to findings visible on FDG-PET only (12/39, 31.8%) and find-
ings visible on both FDG-PET and CT (5/39, 12.8%). 
4. Discussion 
The results of this study show that diagnostic errors in clinical FDG- 
PET/CT, as identified by addenda to the original report, are relatively 
infrequent (around 2%) but nevertheless non-negligible. Perceptual 
Fig. 6. A 71-year-old man with a history of liver transplantation and recent 
episodes of epilepsy with abnormalities in the left occipital lobe on CT (not 
shown). Low-dose FDG-PET/CT was performed to evaluate for post-transplant 
lymphoproliferative disorder. FDG-PET/CT showed pathologic FDG uptake in 
the left occipital lobe (not shown). Axial fused FDG-PET/CT (A) and low-dose 
CT (B) are demonstrated. FDG-PET showed focal high FDG uptake in the 
upper esophagus (A, arrow) with focal wall thickening on low-dose CT (B, 
arrow), which was interpreted to be most likely of physiological nature in the 
original report. However, this lesion proved to be esophageal cancer on follow- 
up. This cognitive error was corrected with an addendum 15 days after 
authorization of the original report. 
Fig. 7. A 77-year-old woman with a history of colon cancer, oropharyngeal 
cancer, and recently diagnosed esophageal cancer. Low-dose FDG-PET/CT and 
concomitant full-dose contrast-enhanced CT were performed for staging pur-
poses. FDG-PET/CT showed pathologic FDG uptake in the esophageal cancer 
and several FDG-avid locoregional lymph nodes (not shown). Axial CT in lung 
window settings (A) and FDG-PET (B) are demonstrated. CT shows a 5-mm 
pulmonary nodule (A, arrow) without any visible FDG uptake at PET (B). 
This nodule was considered suspicious for metastatic disease in the original 
report. However, this nodule was also present at CT performed 2 years before. 
Therefore, it was highly unlikely to represent a lung metastasis. This cognitive 
error was corrected with an addendum one day after authorization of the 
original report. 
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errors outnumbered cognitive errors with a ratio of 60% to 40%. This 
60% perceptual error proportion is relatively on the lower end when 
compared to the previously quoted 60%-80% perceptual error propor-
tion of all diagnostic errors in radiological (non-FDG-PET/CT) exami-
nations [2]. The relatively lower proportion of perceptual errors may be 
explained by the fact that, overall, FDG-PET/CT is a relatively sensitive 
imaging modality for the detection of pathology [1]. The relatively 
higher proportion of cognitive errors for FDG-PET/CT in this study may 
in part be explained by the fact that FDG is a non-specific radiotracer. 
Univariately, the availability of a concomitantly acquired and 
interpreted full-dose contrast-enhanced CT, and interpretation of FDG- 
PET/CT by a nuclear medicine physician only, emerged as potentially 
associated with an increased risk of diagnostic error. Multivariately, 
only the former remained significantly associated with an increased risk 
of diagnostic error. Although this finding may appear counterintuitive at 
a first glance, it can be explained by the fact that a full-dose contrast- 
enhanced CT scan contains a lot of structural information and potential 
pathology that may not be visible on low-dose FDG-PET/CT, and can 
thus be overlooked or misinterpreted. Particularly when relying on FDG- 
PET information, satisfaction of search bias may arise (i.e. the visual 
search pattern is discontinued after the interpreting physician has 
become pleased with the findings observed on FDG-PET) [3]. Due to this 
satisfaction of search bias, the interpretation of the concomitantly ac-
quired full-dose contrast-enhanced CT scan may become compromised, 
particularly in terms of more perceptual errors. This hypothesis was 
supported by a post-hoc analysis that demonstrated the proportion of 
perceptual errors to be higher (65.0%) when low-dose FDG-PET/CT was 
combined with full-dose contrast-enhanced CT than when it was not 
(50.0%). In addition, the majority (56.4%) of perceptual errors in the 
setting when diagnostic-quality CT scan was concomitantly performed, 
was due to findings that were visible on CT only. In our department, 
low-dose FDG-PET/CT is interpreted before full-dose contrast-enhanced 
CT, and the low-dose FDG-PET/CT scan and the corresponding pre-
liminary report are available for review to the full-dose con-
trast-enhanced CT reader. This workflow may introduce satisfaction of 
search errors. Nuclear medicine physicians and radiologists should be 
conscious of this potential pitfall when reading FDG-PET/CT, and adjust 
their workflow or mindset accordingly. 
Interestingly, in a previous survey study among 663 referring phy-
sicians on their experience with the interpretation of oncological FDG- 
PET/CT studies, perceived misinterpretation rates ranged from 5% to 
20%, according to 59.3% of the participants [7]. Overinterpretation 
rather than underinterpretation was more frequently encountered ac-
cording to the referring physicians (68.9% vs. 8.7%, respectively) [7]. 
Limited availability of a patient’s history and limited experience of in-
terpreters were the major contributors to this phenomenon, according to 
46.8% and 26.7% of the participants in this survey, respectively [7]. 
Provision of adequate history when ordering an examination and 
multidisciplinary meetings may indeed reduce diagnostic errors. How-
ever, on the basis of the results of the present study, reader experience 
does not affect diagnostic error rate. 
Addenda are made with the purpose to correct or expand on an 
original radiology report [4], and they can be used as a valuable source 
to study errors [5]. In a previous study on this topic, 5,568 (0.8 %) of all 
Fig. 8. A 47-year-old woman with a history of 
breast cancer and mastectomy, and focally 
increased uptake in several ribs on recently 
performed bone scintigraphy (not shown). Low- 
dose FDG-PET/CT was performed to evaluate 
for metastatic disease. Axial fused FDG-PET/CT 
(A, C, E) with corresponding low-dose CT (B, D, 
F) slices at three different levels are demon-
strated. FDG-PET showed slight FDG uptake 
around the breast prosthesis (A, arrowhead), 
but also high FDG uptake in the soft tissues in 
the left axilla (C and E, arrows) and in a left 
internal mammary lymph node (C, arrowhead), 
and focally increased FDG uptake in a right- 
sided rib (E, arrowhead), which were inter-
preted as recurrent metastatic breast cancer in 
the original report. However, before FDG-PET/ 
CT it was already known that the breast implant 
was leaking and that there was an inflammatory 
reaction in the surrounding tissues. This infor-
mation was available in the patient’s clinical 
records, but not in the request form for FDG- 
PET. Based on this information, the increased 
FDG uptake in the soft tissues in the left axilla 
and in the left internal mammary lymph node 
were likely attributable to the leaking breast 
implant. Furthermore, low-dose CT showed 
callus formation in the right-sided rib with 
increased FDG uptake (F, arrowhead), sugges-
tive of fracture. Three-year follow-up did not 
show any signs of metastatic disease. These 
cognitive errors were corrected with an 
addendum 7 days after authorization of the 
original report.   
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719,855 diagnostic radiology reports that were compiled in a tertiary 
care center over a 1-year period (June 2013 to May 2014), contained an 
addendum [5]. In a subanalysis, 228 (26.8 %) of 851 addenda were is-
sued due to perceptual errors [5]. However, the number of cognitive 
errors was not clearly reported, and no analysis was made on frequency, 
types and determinants of diagnostic errors for FDG-PET/CT in that 
study [5]. Other studies on this topic and on diagnostic errors in clinical 
FDG-PET/CT in general are completely lacking. 
The present study had several limitations. First, diagnostic errors 
extracted from addenda do not yield all diagnostic errors that are made 
in clinical FDG-PET/CT reading. Therefore, the true number of diag-
nostic errors is undoubtedly higher. However, peer review of all indi-
vidual FDG-PET/CT scans for diagnostic errors is challenging, because 
the definition of “truth” varies, even among experienced radiologists [5, 
8]. The use of addenda for analysis of diagnostic errors has been re-
ported to be a more reproducible method [5]. It should be mentioned 
that the use of addenda may not be a common practice in all countries 
and institutions. Nevertheless, for imaging departments that already use 
an addenda system in routine clinical practice, the findings of the pre-
sent study can be used for benchmarking purposes. Second, several other 
variables that were not analyzed in the present study, may be associated 
with diagnostic error rate, such as the availability of adequate clinical 
information, and previous imaging before FDG-PET/CT. 
In conclusion, diagnostic errors in clinical FDG-PET/CT based on 
addenda to the original report are relatively infrequent, though certainly 
non-negligible. Perceptual errors are slightly more frequent than 
cognitive errors. The availability of a concomitantly acquired and 
interpreted full-dose contrast-enhanced CT seems to increase diagnostic 
error rate. These data can be used for quality improvement and bench-
marking purposes. 
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Table 3 
Results of univariate and multivariate logistic regression analysis on the asso-
ciation between patient, FDG-PET/CT acquisition, and FDG-PET/CT interpre-
tation variables with the presence of a diagnostic error.  
Variable 










Patient age 0.99 0.99- 
1.01 
0.48    




0.45    




0.18    
Clinical indication for 
FDG-PET/CT       
-Oncology vs. others 1.52 0.56- 
4.17 
0.42    
-Infection vs. others 1.32 0.39- 
4.45 










enhanced CT vs. 
low-dose FDG-PET/ 




<0.001 2.79 1.61- 
4.85 
<0.001 














0.44    
FDG-PET/CT read by 
nuclear medicine 
physician only vs. 
FDG-PET/CT scan 










a Only medical imaging specialists (radiologists or nuclear medicine physi-
cians) were counted. 
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